An expert multidisciplinary panel in the treatment of type B aortic dissection reviewed
available literature to develop treatment algorithms using a consensus method. Data from 63 …

OBJECTIVE AND DESIGN: The role of Thoracic Endovascular Repair (TEVAR) in chronic
type B aortic dissection remains controversial and its mid-term success as an alternative to …

Background The classification of aortic dissection into acute (< 14 days from symptom onset)
versus chronic (≥ 14 days) is based on survival estimates of patients treated decades …

Introduction Despite a current lack of US Food and Drug Administration approval for the
indication, thoracic endovascular aortic repair (TEVAR) has replaced open surgical …

Stroke is a devastating complication of thoracic endovascular aortic repair (TEVAR).
Whether left subclavian artery (LSA) coverage and LSA revascularization affect stroke rate is …

OBJECTIVES: The study aimed to investigate early and long-term outcome of thoracic
endovascular aortic repair (TEVAR) for acute complicated type B dissection. DESIGN: This …

Background Type B aortic dissection (TBAD), is defined as a dissection involving the aorta
distal to left subclavian artery with the ascending aorta and the aortic arch not affected …

BACKGROUND: The Food and Drug Administration has approved devices for endovascular
management of thoracic endovascular aortic aneurysm repair (TEVAR); however, limited …

OBJECTIVE: Hybrid repair of the transverse aortic arch may allow for aortic arch repair with
reduced morbidity in patients who are suboptimal candidates for conventional open surgery …

OBJECTIVE: Thoracic endovascular aortic repair for chronic type B aortic dissection with
associated descending thoracic aneurysm remains controversial. Concerns include …